Keybank National Association OH Has $35.35 Million Position in Cigna Group $CI

Keybank National Association OH lowered its position in Cigna Group (NYSE:CI) by 2.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 128,435 shares of the health services provider’s stock after selling 3,061 shares during the quarter. Keybank National Association OH’s holdings in Cigna Group were worth $35,349,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in CI. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC increased its stake in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares during the period. NewEdge Advisors LLC increased its stake in shares of Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina increased its stake in shares of Cigna Group by 16.6% in the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. acquired a new position in shares of Cigna Group in the second quarter valued at approximately $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several recent research reports. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Piper Sandler decreased their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Mizuho set a $325.00 target price on shares of Cigna Group in a research report on Friday, January 9th. Jefferies Financial Group decreased their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Finally, Truist Financial increased their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $332.47.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Performance

NYSE:CI opened at $292.16 on Thursday. The company has a market capitalization of $76.99 billion, a PE ratio of 13.17, a P/E/G ratio of 0.98 and a beta of 0.26. The company has a 50 day simple moving average of $274.24 and a two-hundred day simple moving average of $276.84. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts anticipate that Cigna Group will post 30.32 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.